Bigbear Pharmaceutical·Medication Guide

• What should be done in case of an olaparib overdose

  Currently, no clear clinical manifestations of overdose have been identified. There have been isolated cases where patients took 900 mg of olaparib ta···【Read More】

  Update: 2026-03-06Source: Haiou HealthViews: 109

• What should be done if a dose of olaparib is missed

  If you forget to take your medication on time, do not take a missed dose. Simply take the next scheduled dose at your regular time. It is particularly···【Read More】

  Update: 2026-03-06Source: Haiou HealthViews: 113

• How long does the effect of olaparib generally last

  After a single 300 mg dose of olaparib, the average time for the drug concentration in the blood to decrease from its peak value by half is 14.9 hours···【Read More】

  Update: 2026-03-06Source: Haiou HealthViews: 112

• How long does it usually take for olaparib to start working

  Olaparib is rapidly absorbed after oral administration. In most people, the drug concentration in the blood reaches its maximum level approximately on···【Read More】

  Update: 2026-03-06Source: Haiou HealthViews: 111

• FDA Approves Lynparza (olaparib) Plus Abiraterone and Prednisone or Prednisolone for Treatment of Ad

  Key Approval HighlightsThe Lynparza combination demonstrated a clinically meaningful reduction in the risk of disease progression or death in the Phas···【Read More】

  Update: 2026-03-06Source: Haiou HealthViews: 117

• Olaparib: Indications, Mechanism, Side Effects and Precautions Overview

  Olaparib is a PARP inhibitor, mainly used for the treatment of specific types of cancers, such as ovarian cancer, breast cancer, and prostate cancer w···【Read More】

  Update: 2026-03-06Source: Haiou HealthViews: 122

• Drug Interactions of Olaparib

  Olaparib is a PARP inhibitor that acts by inhibiting PARP enzyme activity to block DNA damage repair.What Symptoms Can Olaparib Relieve?In the mainten···【Read More】

  Update: 2026-03-06Source: Haiou HealthViews: 117

• What happens if I miss a dose of Abemaciclib

  Take abemaciclib as soon as you can, but skip the missed dose if it is almost time for your next dose. Do not take two doses at one time.If you vomit ···【Read More】

  Update: 2026-03-06Source: Haiou HealthViews: 118

• What other drugs will affect abemaciclib

  Sometimes it is not safe to use certain medicines at the same time. Some drugs can affect your blood levels of other drugs you use, which may increase···【Read More】

  Update: 2026-03-06Source: Haiou HealthViews: 117

• What should I avoid while taking abemaciclib

  Avoid taking ketoconazole during treatment with abemaciclib. Tell your healthcare provider if you take a medicine that contains ketoconazole.Avoid gra···【Read More】

  Update: 2026-03-06Source: Haiou HealthViews: 112

• What is abemaciclib

  Abemaciclib is used to treat HR-positive and HER2-negative breast cancer in adults. It is a targeted treatment, not a chemotherapy drug (see Is Verzen···【Read More】

  Update: 2026-03-06Source: Haiou HealthViews: 114

• FDA Approves Verzenio (abemaciclib) for Certain Advanced or Metastatic Breast Cancers

  FDA Approval AnnouncementSeptember 28, 2017 -- The U.S. Food and Drug Administration (FDA) approved Verzenio (abemaciclib) to treat adult patients wit···【Read More】

  Update: 2026-03-06Source: Haiou HealthViews: 114

• Lilly Receives Additional FDA Approval for Verzenio (abemaciclib), as Initial Treatment for Advanced

  FDA Approval AnnouncementINDIANAPOLIS, Feb. 26, 2018 /PRNewswire/ -- Eli Lilly and Company announced that the U.S. Food and Drug Administration (FDA) ···【Read More】

  Update: 2026-03-06Source: Haiou HealthViews: 117

• FDA Approves Verzenio (abemaciclib) as the First and Only CDK4/6 Inhibitor for Certain People with H

  FDA Approval AnnouncementINDIANAPOLIS, Oct. 13, 2021 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) approved Eli Lilly and Company’s Verz···【Read More】

  Update: 2026-03-06Source: Haiou HealthViews: 112

• FDA Broadens Indication for Verzenio (abemaciclib) in HR+, HER2-, Node-Positive, High Risk Early Bre

  FDA Approval AnnouncementINDIANAPOLIS, March 3, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Adm···【Read More】

  Update: 2026-03-06Source: Haiou HealthViews: 117